loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2009_034___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    VUP Medical

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PharmaCompass

    Inke S.A: APIs manufacturing plant.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 VUP MEDICAL, A.S. Brno CZ (1)

    filter

    01 Collagen (1)

    filter

    01 Czech Republic (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    VUP MEDICAL, A.S. Brno CZ

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag Czech Republic
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Collagen

      PDF Supplier PDF
      URL Supplier Web Content
      R1-CEP 2009-034 - Rev 00
      Valid
      TSE
      2015-02-18
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for Certificates of Suitability (CEPs) for R1-CEP 2009-034 - Rev 00 of Vup Medical, A.s. Brno Cz

      Looking for Certificates of Suitability (CEPs) for R1-CEP 2009-034 - Rev 00 of Vup Medical, A.s. Brno Cz 1

      20

      Vup Medical, A.s. Brno Cz, based in Czech Republic, is a pharmaceutical company.

      One of their significant offerings is Collagen, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2009-034 - Rev 00

      This TSE Type CEP, issued on February 18, 2015, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

      Post Enquiry
      POST ENQUIRY